We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance.
- Authors
Weng, Chao-Yuan; Kao, Cheng-Xiang; Chang, Te-Sheng; Huang, Yen-Hua; Strauss, Laura
- Abstract
The use of immune checkpoint inhibitors (ICI) in treating cancer has revolutionized the approach to eradicate cancer cells by reactivating immune responses. However, only a subset of patients benefits from this treatment; the majority remains unresponsive or develops resistance to ICI therapy. Increasing evidence suggests that metabolic machinery in the tumor microenvironment (TME) plays a role in the development of ICI resistance. Within the TME, nutrients and oxygen are scarce, forcing immune cells to undergo metabolic reprogramming to adapt to harsh conditions. Cancer-induced metabolic deregulation in immune cells can attenuate their anti-cancer properties, but can also increase their immunosuppressive properties. Therefore, targeting metabolic pathways of immune cells in the TME may strengthen the efficacy of ICIs and prevent ICI resistance. In this review, we discuss the interactions of immune cells and metabolic alterations in the TME. We also discuss current therapies targeting cellular metabolism in combination with ICIs for the treatment of cancer, and provide possible mechanisms behind the cellular metabolic rewiring that may improve clinical outcomes.
- Subjects
IMMUNE checkpoint inhibitors; TREATMENT effectiveness; CELLULAR therapy; TUMOR microenvironment; PROGRAMMED cell death 1 receptors; CANCER treatment; CELL metabolism
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 3, p1258
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22031258